September 30, 2022 September 30, 2022Categories News StoriesAdvanced melanoma survival improves significantly when immunotherapy is given before targeted therapy
September 28, 2022 September 28, 2022Categories News StoriesImmunotherapy before targeted therapy improves survival in advanced melanoma, according to the DREAMseq trial
September 27, 2022 September 27, 2022Categories Press ReleasesMedia Advisory: Journal of Clinical Oncology publishes outcomes from the practice-changing DREAMseq trial in patients with advanced melanoma
June 6, 2022 June 6, 2022Categories News StoriesDr. Michael Atkins discusses the DREAMseq trial in patients with advanced melanoma
May 27, 2022 May 27, 2022Categories Press ReleasesPress Release: ECOG-ACRIN research highlights at ASCO 2022
May 17, 2022 May 17, 2022Categories Press ReleasesMedia Advisory: ECOG-ACRIN data at ASCO will showcase the Group’s robust research portfolio
May 5, 2022 May 5, 2022Categories News StoriesThe current state of metastatic melanoma (a series of four videos)
November 26, 2021 November 26, 2021Categories News StoriesTreatment sequence impacts survival in BRAF-mutant metastatic melanoma
November 16, 2021 November 16, 2021Categories Press ReleasesPress Release: Practice-changing trial results for advanced skin cancer
